[1]
Alany, B. T. and AbdulSahib, M. 2026. Tocilizumab and IL-6 Signaling in Rheumatoid Arthritis: Clinical Implications for Infection Detection and CRP Limitations (Narrative Review with a Retrospective Case Series). Journal of Pharmacology and Drug Development. 4, 1 (Jun. 2026), 49–60.